indacaterol/glycopyrronium/mometasone furoate (Enerzair Breezhaler)
As a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
